Team:Evry/Biology/Transposons
From 2014.igem.org
Line 107: | Line 107: | ||
<div align="center">d) Integration of transposons in Pseudovibrio <i>denitrificans</i></div> | <div align="center">d) Integration of transposons in Pseudovibrio <i>denitrificans</i></div> | ||
- | Here, we tried to proved that there was actually a random integration of the transposon in the strain's genome. | + | Here, we tried to proved that there was actually a random integration of the transposon in the strain's genome. To achieve this, we performed a reverse PCR. |
<img src="https://static.igem.org/mediawiki/2014/a/af/Evry_Genome_cut_religated.JPG"/><br> | <img src="https://static.igem.org/mediawiki/2014/a/af/Evry_Genome_cut_religated.JPG"/><br> | ||
Line 118: | Line 118: | ||
<br/> | <br/> | ||
<br/> | <br/> | ||
- | <div align="center">The transformation of Pseudovibrio <i>denitrificans</i> | + | <div align="center">The transformation of Pseudovibrio <i>denitrificans</i> has been verified by the study of its phenotype and its genotype. We therefore confirm the efficiency of the transposon system in our bacteria. c</div> |
<br><br> | <br><br> | ||
Line 124: | Line 124: | ||
<h4> <b>Creation of Transposon Plasmid </b></h4> | <h4> <b>Creation of Transposon Plasmid </b></h4> | ||
</FONT> | </FONT> | ||
- | The second part | + | The second part of our work consisted in introducing our construction in this plasmid. A problem we had to face though was the presence of biobrick restriction sites in our plasmid. We decided to modify our Transposon plasmid so it would no longer have those restriction sites. |
- | <br> | + | <br>Here is the schema of our project. |
<img src="https://static.igem.org/mediawiki/2014/a/a5/Schema_4bis.png"/><br> | <img src="https://static.igem.org/mediawiki/2014/a/a5/Schema_4bis.png"/><br> | ||
- | + | Our aim was to merged pSB1C3 and pNK2 into a single plasmid, in order to have a plasmid that would replicate in non-pir cells. Also, our goal was to have a plasmid matching the requirements of the biobrick format. Here we used the pSB1C3 plasmid as the backbone. | |
- | <br> | + | <br> To isolate the two plasmids it would be possible to digeste the merged plasmid with BglII and then extract by gel eletrophoresis our Transposon plasmid, which only contains the core elements needed for the transposition. Between the two transposable elements iS10 we will eventually integrate the biobrick prefix and suffix to be able to integrate any biobrick in a genome. |
<br> | <br> | ||
<br> | <br> | ||
- | + | As a first step, we have to amplify and assemble each element by the Golden Gate assembly method. | |
<img src="https://static.igem.org/mediawiki/2014/1/15/Schema_8_%281%29.png"/><br> | <img src="https://static.igem.org/mediawiki/2014/1/15/Schema_8_%281%29.png"/><br> | ||
<ol> | <ol> | ||
- | <b><li> Mutation | + | <b><li> Mutation of oRiVR6Kgamma</b> |
- | + | The first issue we encountered was the presence of XbaI restriction sites in the OriVR6Kgamma sequence. Thus, before amplifying it with Golden Gate overhangs, we had to induce mutations in that site of the plasmid using PCR mutagenesis. | |
- | <br> | + | <br> pNK2 plasmid was amplified with primers allowing us to modify the XbaI site : 5' TCTAGA 3' en 5' ACTAGA 3'. |
- | <br> | + | <br> After amplification of the plasmid, we purified the PCR products obtained and transformed several colonies we got. Many colonies were inoculated in liquid cultures supplemented with kanamycin (50µg/mL) and the pNK2 plasmid was finally extracted. Those plasmids were digested by XbaI in order to verify the mutation of the XbaI site. |
<br> | <br> | ||
Revision as of 03:00, 18 October 2014
Biology - Transposons
Transposon
Transposons, known as mobile elements or transposable elements, are DNA sequences able to move randomly within the genome. This phenomenon is based on different transposition mechanisms. One of them, the cut-and-paste mechanism, requires an enzyme named transposase. Transposases bind to the end of transposons sequences, which consist of inverted repeats and then catalyze the excision and insertion of the transposons into the genome.
Transposase Tn10 / IS10
The complex Tn10/IS10 is involved in the non-replicative cut-and-paste mechanism. The transposable segment is excised at its ends and is then re-inserted randomly in a DNA site.
The Tn10 transposase protein is made of 402 amino-acids, which recognises inverted repeats insertion sequence; Is10-right and Is10-left. The Tn10 protein expression is strongly regulated by various positive and negative regulation mechanisms.
IS 10 is an insertion sequence composing the transposon Tn10. The two IS10 elements, IS10-Right and IS10-Left, contain all of the Tn10 encoded genetic determinants; as the coding region of the transposase protein Tn10. The two ends of IS-10 have a similar terminal inverted repeat of 23 bp, corresponding to the transposase binding site. However, some genetic drifts occurring between both of these sequences caused variation in their functionality. Indeed, IS10-right is fully functional while IS10-left is partially functional.
Our project
We tested different plasmids and methods to transform Pseudovibrio denitrificans but yet unsuccessfully. Thus, the integration in the genome was tested. Doctor Brian Jester gave us the pNK2 plasmid and DH5α pir cells. In fact, the plasmid pNK2 contains a particular origin of replication OriVR6Kgamma. This ORI VR6K gamma is controlled by the pi protein, which is encoded by the pir gene. Indeed, the pi protein allows the replication of the plasmid by binding a particular site in the ORI sequence. Hence, the oriVR6K gamma can only be replicated in a bacterial strain producing the pi protein. This ori was already used in the iGEM competition in 2009 by a french team. The gamma origin is adjacent to the pi protein binding site and other sites bounded by the host cell proteins involved in its own reproduction.
Insertion of transposon
- Transformation Pseudovibrio denitrificans with pNK2
- Phenotypic verification
- Genotypic verification
- Mutation of oRiVR6Kgamma The first issue we encountered was the presence of XbaI restriction sites in the OriVR6Kgamma sequence. Thus, before amplifying it with Golden Gate overhangs, we had to induce mutations in that site of the plasmid using PCR mutagenesis.
We tested pNK2 by transforming Pseudovibrio denitrificans bacteria with the plasmid by electroporation. The selection of cells was performed in 1X marine broth medium supplemented with kanamycine 50µg/mL. In fact, Pseudovibrio denitrificans can grow on medium with kanamycine 25µg/mL. (Sensitivity to antibiotics)
Fig. 3 Image of Pseudovibrio denitrificans colonies in a petri dish containing kanamycin. Pseudovibrio denitrificans were previously transformed with the pNK2-CRPIIh plasmid.
Fig. 4 Growth curve of Pseudovibrio denitrificans in M9 supplemented with casamino acids and 3% NaCl
The kanamycin gene is included in the transposon sequence of pNK2 and we thus amplify this gene for our verification PCR.
We successfully obtained an amplicon corresponding to the kanamycin gene in our transformed cells. Considering the plasmids are not able to be replicated in an other strain than pir cells, we assumed the amplification we obtained were from ADNg and not from plasmids.
As a first verification, we obtained this gel for 15 colonies of Pseudovibrio denitrificans.
The amplification of transformed cells' DNA with primers 16S, which amplify the sequence of the ribosome 16S, were purified and sent to sequencing.
The sequence we obtained proves that we transformed actual Pseudovibrio bacteria with an integrated transposon.
This sequence is the following (read of 1000 bp):
GACGGTGTCATTGATCTGGATAATGTCAACGAGCAGACCGGATCTTATCAGTTTGTCGGTGATGATGGGTTTGATACGGCAGGGCGCAGTATCTCTTCAGCTGGTGATG
TTGATGGTGATGGTAAGGATGATCTGCTCATCGGTGCTGCGAATGCTAATGGTAGTGGTGCCAACCAAGGATCCGCTTCAGGGGCTGCTTATCTGATGACGGCTTCTGCACTA
GCAGCCGCTGATGCCGCTGACGGCACCACTGATGGTGTTATTGATTTGGGTAATGTCAATGAGCAGACTGGATCTTATCAGTTCAATGGTACAGAAGTAATGGACCAAGCCGG
AACTCGTGTAACATCTGCAGGCGATGTGGATGGCGATGGCAAAGATGATGTCTTTATCAGCAGCATTTTTGCAGATGATGGCGGCTCCAGTTCTGGTGAAGCATATTTGCTGA
CAGCTGCTGCTATGGCTTCAGCTGATGCCGCTGACGGCACTACTGACGGCATCATTGATTTGGACAATGTCAATGAGCAAACCAACTCTTATCAGTTTGTTGGCACCCAAGCA
GATGACCTGGCCGGCATTGATATCTCAGCTGCTGGTGATGTTGATGGCGATGGCAAAAATGACTTCTTGATCGGTGCTCGGGCAGCAGATGGTGGCGGCGCTGGCTCGGGTGA
GGCCTATCTGTTGACTGCAGCAGCACTTGCTTCAGCTGATGCAGCTGATGGCACCACTGATGGGATTATCGATCTAGATAATGTCAATGAGCAGACTAACTCTTATCAGTTCG
TTGGTACGGAAGTTGGCGATGATGCGGGAATTAGCGTGTCATTTGTCGGTGATGTTGACAATGATGGTAAGGACGATCTGTTGATTGGTGCACGTAATGCTGACGGCGGTGGC
TCCAACTCTGGTGAAGCCTATCTAATGTCTATTGCTTCACTGGCGACTGCTGATGCAGCTGATGGCACCATTGATGGTGTTATCGATTTGGAT
paragraphe romain sur l'image
Creation of Transposon Plasmid
The second part of our work consisted in introducing our construction in this plasmid. A problem we had to face though was the presence of biobrick restriction sites in our plasmid. We decided to modify our Transposon plasmid so it would no longer have those restriction sites.Here is the schema of our project.
Our aim was to merged pSB1C3 and pNK2 into a single plasmid, in order to have a plasmid that would replicate in non-pir cells. Also, our goal was to have a plasmid matching the requirements of the biobrick format. Here we used the pSB1C3 plasmid as the backbone.
To isolate the two plasmids it would be possible to digeste the merged plasmid with BglII and then extract by gel eletrophoresis our Transposon plasmid, which only contains the core elements needed for the transposition. Between the two transposable elements iS10 we will eventually integrate the biobrick prefix and suffix to be able to integrate any biobrick in a genome.
As a first step, we have to amplify and assemble each element by the Golden Gate assembly method.
pNK2 plasmid was amplified with primers allowing us to modify the XbaI site : 5' TCTAGA 3' en 5' ACTAGA 3'.
After amplification of the plasmid, we purified the PCR products obtained and transformed several colonies we got. Many colonies were inoculated in liquid cultures supplemented with kanamycin (50µg/mL) and the pNK2 plasmid was finally extracted. Those plasmids were digested by XbaI in order to verify the mutation of the XbaI site.